innosferaНаука и инновацииScience and Innovations1818-98572412-9372Издательский дом «Белорусская наука»10.29235/1818-9857-2022-2-24-35innosfera-35Research ArticleБИОМЕДИЦИНСКИЕ АСПЕКТЫ ИММУНОЛОГИИНовые биомедицинские клеточные продукты для иммунотерапии заболеваний человекаCharacteristics of the immunity system in patients with pneumonia associated with COVID‑19БобрукевичД.BobrukevichD.

Дарья Бобрукевич, младший научный сотрудник лаборатории иммунологии и клеточной биофизики

Daria Bobrukevich

bobrukevich.darya@gmail.comАнтоневичН.AntonevichN.

Наталья Антоневич, завлабораторией иммунологии и клеточной биофизики, кандидат биологических наук

Natalya Antonevich  

antonevich.n@gmail.comГончаровА.HancharouA.

Андрей Гончаров, директор, кандидат медицинских наук, доцент

Andrei Hancharou

andrei.hancharou@gmail.comРындаЕ.RyndaE.

Елена Рында, научный сотрудник лаборатории иммунологии и клеточной биофизики

Elena Rynda

alenarynda@gmail.comТимохинаО.TimokhinaO.

Оксана Тимохина, научный сотрудник лаборатории иммунологии и клеточной биофизики

Oksana Timokhina

oksanabuschik@gmail.comМиничЯ.MinichYa.

Яна Минич, младший научный сотрудник лаборатории иммунологии и клеточной биофизики

Yana Minich

yana-minich@tut.byГоловачЕ.GolovachE.

Елена Головач, младший научный сотрудник лаборатории иммунологии и клеточной биофизики

Elena Golovach

elenabriche@mail.ruДоценкоМ.DotsenkoM.

Марина Доценко, заместитель заведующего кафедрой инфекционных болезней, доктор медицинских наук, профессор

Marina Dotsenko

mar_dots@mail.ruДоценкоЭ.DotsenkoE.

Эдуард Доценко, заведующий кафедрой пропедевтики внутренних болезней, доктор медицинских наук

Eduard Dotsenko

ed_dots@mail.ruИнститут биофизики и клеточной инженерии НАН БеларусиBelarusБелорусский государственный медицинский университетBelarus202227042022022435Copyright © Издательский дом «Белорусская наука», 20222022Издательский дом «Белорусская наука»Издательский дом «Белорусская наука»https://innosfera.belnauka.by/jour/about/submissions#copyrightNoticehttps://innosfera.belnauka.by/jour/article/view/35

Проведен расширенный анализ иммунных параметров, характеризующих дифференцировку, активацию и истощение лимфоцитов, моноцитов и гранулоцитов у пациентов со среднетяжелой и тяжелой пневмонией COVID-19.

The advanced analysis of immune parameters describing differentiation profile, activation and exhaustion of lymphocytes, monocytes and granulocytes of patients with moderate and severe/critical COVID‑19 pneumonia was performed.

COVID-19SARS-CoV-2иммунитетпневмонияиммунные параметрыCOVID‑19SARS‑CoV‑2immu‑ nitypneumoniaimmune parametersReferencesSustained cellular immune dysregulation in individuals recovering from SARS CoV 2 infection / Files J. K. [et al.] // The Journal of Clinical Investigation. 2020. №1. P. 131Sustained cellular immune dysregulation in individuals recovering from SARS CoV 2 infection / Files J. K. [et al.] // The Journal of Clinical Investigation. 2020. №1. P. 131Coronavirus infections and immune responses / Li G. [et al.] // Journal of medical virology. 2020. V. 92. №4. P. 424–432.Coronavirus infections and immune responses / Li G. [et al.] // Journal of medical virology. 2020. V. 92. №4. P. 424–432.The clinical course and its correlated immune status in COVID 19 pneumonia / Ruyuan He. [et al.] // Journal of Clinical Virology. 2020. №7. P. 127.The clinical course and its correlated immune status in COVID 19 pneumonia / Ruyuan He. [et al.] // Journal of Clinical Virology. 2020. №7. P. 127.De Virgiliis, F. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID 19 / De Virgiliis F., Di Giovanni S. // Nature Reviews Neurology. 2020. №11, Vol. 16. P. 1–8.De Virgiliis, F. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID 19 / De Virgiliis F., Di Giovanni S. // Nature Reviews Neurology. 2020. №11, Vol. 16. P. 1–8.Characteristics of peripheral lymphocyte subset alteration in COVID 19 pneumonia / Wang F. [et al.] // The Journal of infectious diseases. 2020. V. 221. №11. P. 1762–1769.Characteristics of peripheral lymphocyte subset alteration in COVID 19 pneumonia / Wang F. [et al.] // The Journal of infectious diseases. 2020. V. 221. №11. P. 1762–1769.Phenotype of SARS CoV 2 specific T cells in COVID 19 patients with acute respiratory distress syndrome / Weiskopf D. [et al.] // Sci Immunol. 2020. V. 5. №48. eabd2071Phenotype of SARS CoV 2 specific T cells in COVID 19 patients with acute respiratory distress syndrome / Weiskopf D. [et al.] // Sci Immunol. 2020. V. 5. №48. eabd2071Detection of SARS CoV 2 specific humoral and cellular immunity in COVID 19 convalescent individuals / Ling Ni. [et al.] // Immunity. 2020. V. 52. №6. P. 971–977.Detection of SARS CoV 2 specific humoral and cellular immunity in COVID 19 convalescent individuals / Ling Ni. [et al.] // Immunity. 2020. V. 52. №6. P. 971–977.Suppressed T cell mediated immunity in patients with COVID 19: a clinical retrospective study in Wuhan, China / Bo Xu. [et al.] // The Journal of infection. 2020. V. 81. №1. P. 51–60.Suppressed T cell mediated immunity in patients with COVID 19: a clinical retrospective study in Wuhan, China / Bo Xu. [et al.] // The Journal of infection. 2020. V. 81. №1. P. 51–60.SARS CoV 2 reactive T cells in healthy donors and patients with COVID 19 / Braun J. [et al.] // Nature. 2020. №578. P. 270–274.SARS CoV 2 reactive T cells in healthy donors and patients with COVID 19 / Braun J. [et al.] // Nature. 2020. №578. P. 270–274.In depth phenotyping of human peripheral blood mononuclear cells in convalescent COVID 19 patients following a mild versus severe disease course / Chang Feng Chu. [et al.] // medRxiv. 2020.In depth phenotyping of human peripheral blood mononuclear cells in convalescent COVID 19 patients following a mild versus severe disease course / Chang Feng Chu. [et al.] // medRxiv. 2020.Shared Antigen specific CD8+ T cell Responses Against the SARS COV 2 Spike Protein in HLA A* 02: 01 COVID 19 Participants / Chour W. [et al.] // medRxiv. 2020.Shared Antigen specific CD8+ T cell Responses Against the SARS COV 2 Spike Protein in HLA A* 02: 01 COVID 19 Participants / Chour W. [et al.] // medRxiv. 2020.SARS CoV 2, the virus that causes COVID 19: cytometry and the new challenge for global health / Cossarizza A. [et al.] // Cytometry. 2020. V. 97. №4. P. 340–343.SARS CoV 2, the virus that causes COVID 19: cytometry and the new challenge for global health / Cossarizza A. [et al.] // Cytometry. 2020. V. 97. №4. P. 340–343.Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID 19) / Diao B. [et al.] // Frontiers in Immunology. 2020. №11. P. 827.Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID 19) / Diao B. [et al.] // Frontiers in Immunology. 2020. №11. P. 827.

The authors declare that there are no conflicts of interest present.